Evidence map›Paper›PMID 42394649›Full record

ArticleEuropean heart journal. Imaging methods and practice2026

Cardiac remodelling and clinical outcomes after mitral edge-to-edge repair with the PASCAL® system.

Mareike Bladt, Marius Keller, Meinrad Gawaz, Juergen Schreieck, Andreas Goldschmied, Makoto Amaki, Takashi Matsumoto, Izumo Masaki, Shingo Kuwata, Shunsuke Kubo and 8 more

Abstract read
In one paragraph

Article in European heart journal. Imaging methods and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Mareike BladtDepartment of Cardiology and Angiology, University Hospital Tübingen, Otfried-Müller-Straße 10, Tübingen 72076, Germany.
Marius KellerDepartment of Anaesthesiology and Intensive Care Medicine, University Hospital Tübingen, Hoppe-Seyler-Street 3, Tübingen 72076, Germany.ORCID https://orcid.org/0000-0002-5810-8845
Meinrad GawazDepartment of Cardiology and Angiology, University Hospital Tübingen, Otfried-Müller-Straße 10, Tübingen 72076, Germany.
Juergen SchreieckDepartment of Cardiology, Medius Kliniken gGmbH medius Klinik, Ostfildern-Ruit, Germany.
Andreas GoldschmiedDepartment of Cardiology and Angiology, University Hospital Tübingen, Otfried-Müller-Straße 10, Tübingen 72076, Germany.
Makoto AmakiDepartment of Heart Failure and Transplant, Division of Heart Failure, National Cerebral and Cardiovascular Center, 6-1 Kishibeshinmachi Suita, Osaka 564-8565, Japan.ORCID https://orcid.org/0000-0001-5132-5129
Takashi MatsumotoDepartment of Cardiology and Cath Laboratories, Shonan Kamakura General Hospital, Kamakura, Kangawa, Japan.ORCID https://orcid.org/0000-0002-6603-9181
Izumo MasakiDivision of Cardiology, Department of Internal Medicine, St.Marianna University School of Medicine, Kawasaki, Japan.
Shingo KuwataDivision of Cardiology, Department of Internal Medicine, St.Marianna University School of Medicine, Kawasaki, Japan.
Shunsuke KuboDepartment of Cardiology, Kurashiki Central Hospital, Kurashiki, Japan.ORCID https://orcid.org/0000-0003-4794-7843
Kentaro HayashidaDepartment of Cardiology, Keio University School of Medicine, 35 Shinanomachi, Shinjyuku-ku, Tokyo 160-8582, Japan.ORCID https://orcid.org/0000-0002-1750-1982
Firas ZahrDivision of Cardiovascular Medicine, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, USA.ORCID https://orcid.org/0000-0001-8448-8880
Felix KreidelDepartment of Internal Medicine III, Cardiology and Critical Care, University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller-Straße 3, Kiel 24105, Germany.ORCID https://orcid.org/0000-0003-0884-6572
Fabien PrazDepartment of Cardiology, Inselspital, Bern University Hospital, Freiburgstrasse 18, Bern 3010, Switzerland.ORCID https://orcid.org/0000-0001-5416-165X
Didier TchétchéDepartment of Interventional Cardiology, Clinique Pasteur, Toulouse, France.
Harry MaguniaDepartment of Anaesthesiology and Intensive Care Medicine, University Hospital Tübingen, Hoppe-Seyler-Street 3, Tübingen 72076, Germany.ORCID https://orcid.org/0000-0001-9576-6399
Monika ZdanyteDepartment of Cardiology and Angiology, University Hospital Tübingen, Otfried-Müller-Straße 10, Tübingen 72076, Germany.
Tobias GeislerDepartment of Cardiology and Angiology, University Hospital Tübingen, Otfried-Müller-Straße 10, Tübingen 72076, Germany.ORCID https://orcid.org/0000-0002-8864-6038

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: Chronic mitral regurgitation (MR) causes haemodynamic and myocardial changes leading to increased left atrial volume and left ventricular preload and finally eccentric hypertrophy of the left ventricle. The extent to which mitral valve transcatheter edge-to-edge repair induced haemodynamic improvements translates into reverse remodelling and clinical benefit remains to be clarified. This project aimed to investigate periprocedural haemodynamic changes during mitral valve transcatheter edge-to-edge repair, their effects on reverse cardiac remodelling, and the associated effects on heart failure-related hospitalization and all-cause mortality. Methods and results: In this retrospective study, 130 patients with severe symptomatic MR underwent transcatheter edge-to-edge repair. Haemodynamic parameters were assessed pre- and immediately post-procedure, and echocardiography was performed at 6-12 months (median 188 days, IQR 26). Clinical follow-up included 1-year heart failure hospitalization and all-cause mortality. Short-term haemodynamic data were available in 86 patients and long-term echocardiographic follow-up in 73, with incomplete datasets excluded from the respective analyses. Mitral valve transcatheter edge-to-edge repair significantly improved cardiac index (+11.37%, Conclusion: Mitral valve transcatheter edge-to-edge repair with the PASCAL® system is linked with immediate haemodynamic improvements that may be associated with reverse cardiac remodelling and improved mid-term clinical outcomes. Monitoring acute haemodynamic effects may help predict positive remodelling and outcome effects.

Indexed as

haemodynamic changesmitral regurgitationmyocardial remodellingPASCAL systemtranscatheter edge-to-edge repair

Identifiers

PMID42394649
PMCPMC13326949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.